Stock Report Zydus Lifesciences Ltd. with In-Depth Stock Analysis

Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Falling Comet

868.85 24.45 (2.90%)

1.2M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

US FDA Approval

Zydus Life receives final approval from the US FDA to manufacture Jaythari (Deflazacort) tablets See details

Detailed Stock Analysis for Zydus Lifesciences Ltd. with Real-time Stock Report